Parkman Healthcare Partners LLC Pulmonx Corp Transaction History
Parkman Healthcare Partners LLC
- $770 Million
- Q1 2025
A detailed history of Parkman Healthcare Partners LLC transactions in Pulmonx Corp stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 611,875 shares of LUNG stock, worth $1.92 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
611,875
Previous 207,853
194.38%
Holding current value
$1.92 Million
Previous $1.41 Million
191.78%
% of portfolio
0.53%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding LUNG
# of Institutions
127Shares Held
32.5MCall Options Held
2.6KPut Options Held
216K-
Primecap Management CO Pasadena, CA5.41MShares$17 Million0.03% of portfolio
-
Morgan Stanley New York, NY3.49MShares$11 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$8.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$7.17 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.89MShares$5.93 Million0.32% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $117M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...